I find it hard to understand how some large stake in IPIX hasn't already been taken by some of these players that target companies with very large short positions, especially with the amount of positive expectations for the current CV19 trial.

The fact that Brilacidin is not a one trick pony but an expected broad spectrum platform against viral, bacterial, and inflammatory conditions should give them the confidence that it will succeed on some level and has a great chance to become a /the monster drug of the 21st century.

I discount this entire 'short' opportunity for IPIX in my expectations for future stock appreciation and focus on the science for gains, but one has to realize that when looking at Gamestop, AMC, etc that IPIX should provide an even greater opportunity as the upside seems much more likely than these other firms and the downside (as in total failure) next to nil.

This is going to be a great summer IMO for IPIX.

In the mountains basking in the glory of the Rockies, remembering all the men and women that gave their lives fighting to give us all the opportunity to enjoy this great land. They did their part, hope today's citizens stand a little taller than they have been and start doing theirs.